Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.21.436338Source: DataRank Database

Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Shuai Li ORCID,Alireza Khodadadi‐Jamayran ORCID,Jayu Jen ORCID,Han Han ORCID,Kayla Guidry ORCID

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W3137745249

National Institutes of Health

Grant: 5R01CA248896-05

Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer

National Institutes of Health

Grant: 5P30CA016087-32

Experimental Pathology

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/21/2021.03.21.436338.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.21.436338

repositoryhttps://doi.org/10.1101/2021.03.21.436338

https://dx.doi.org/10.1101/2021.03.21.436338

Fields of Study

Protein Tyrosine PhosphatasesImmune cells in cancerGalectins and Cancer Biology0301 basic medicine03 medical and health sciences

Keywords

Cancer researchKRASCytotoxic T cellMAPK/ERK pathwayTumor microenvironmentMEK inhibitorChemistryCD8KinaseBiologyCancerCell biologyMedicineImmunologyColorectal cancerImmune systemInternal medicineIn vitro

Sustainable Development Goals

SDG 3: 3. Good health